Healthy Living

Drop in routine childhood vaccinations during coronavirus may spur increase in preventable illness, CDC warns

A marked decline in routine childhood vaccinations during the coronavirus pandemic may lead to an increase in preventable diseases, the Centers for Disease Control and Prevention (CDC) warned on Thursday.

2 FDA committee members resign over Biogen Alzheimer's drug approval

Fallout over the FDA’s recent decision to grant Biogen’s Alzheimer’s drug accelerated approval has seen two advisory panel members resign.

Moderna seeks COVID-19 vaccine authorization for teens

Moderna announced on Thursday that it had requested the FDA grant emergency use authorization for its COVID-19 vaccine in adolescents.

More than 170 Houston hospital workers suspended over refusing vaccine

More than 170 health care workers at a Houston, Texas, hospital were reportedly suspended for two weeks without pay for choosing to not get the coronavirus vaccine by the hospital’s Monday deadline, which the hospital requires of its workers.

Who should take new Alzheimer's drug? Expert weighs in

After the Food and Drug Administration granted approval to the first Alzheimer’s drug in nearly two decades, Biogen's Aduhelm (aducanumab), doctors are left triaging patient calls in a bid to find the appropriate patient with a mild, early course of disease.

FDA OK's Biogen's Alzheimer's drug: What is Accelerated Approval?

The Food and Drug Administration on Monday approved Biogen’s Alzheimer’s drug albeit to mixed reviews.

Pfizer lowers COVID-19 vaccine doses for younger kids in clinical trial

Pfizer said it has selected lower dosages of its COVID-19 vaccine for Phase 2/3 portions of its clinical trial involving kids younger than 11 than the volume given to shot recipients ages 12 and older.

COVID-19 vaccine trials in kids 5 and up begin

Seven-year-old Russell Bright squeezed his dad’s hand tightly as tests of Pfizer's COVID-19 vaccine started Monday in Louisiana for children ages 5 through 11.

FDA approval of Biogen's Alzheimer's drug leaves some 'disappointed'

Government health officials on Monday approved the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow the brain-destroying disease.

FDA approves new weight loss drug, first since 2014

The Food and Drug Administration (FDA) on Friday approved a weight loss drug for overweight or obese adults, marking the first such authorization since 2014.